Interview 28 May 2019 Getting Ahead of the Pack in the CAR-T Field Celyad is one of many companies in the immuno-oncology field seeking to take the lead in the development of a new generation of CAR-T cell therapy that outperforms its predecessors Yescarta and Kymriah in both efficacy and safety. Filippo Petti, CEO of Celyad, shares the company’s strategy to get ahead in such a crowded field. […] May 28, 2019 - 6 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
More News! 23 May 2019 Irish Life Sciences VC Raises €118M Fund with European Focus Fountain Healthcare Partners has raised €118M in its third fund dedicated to investing in life sciences, with the majority of the funds destined to go to European companies. Of the total raised, €45M was contributed by the European Investment Fund, which invested in both of Fountain’s previous funds. Other investors are Coolidge Limited, the Ireland […] May 23, 2019 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Interview 16 May 2019 Taking a Drug to Market “Is a Marathon, Not a Sprint” Based in Zurich, Molecular Partners is developing a new class of drugs that can address the complexity of cancer. At Labiotech Refresh in Zurich, CEO Patrick Amstutz shared what he’s learned on the journey to take the company where it is today. After completing a PhD at ETH Zurich, Amstutz founded Molecular Partners with a […] May 16, 2019 - 4 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
In Depth 15 May 2019 The Missing Piece in the Microbiome Field Over the last decade, the biotech industry has built a lot of hype around the emerging field of microbiome research. Its potential to treat all sorts of diseases has captured the imagination of scientists and the number of early-stage studies is growing massively day by day. These studies have found correlation between the human microbiome […] May 15, 2019 - 7 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Interview 9 May 2019 A 20-Year Journey to Nail Down an Undruggable Cancer Target The ultimate goal of cancer research is to bring to the market a drug that improves the treatment of patients lacking options. Laura Soucek, CEO of the startup Peptomyc, shares the story of her journey to take a cancer treatment against an until now undruggable target to the clinic. It all started when Soucek was […] May 9, 2019 - 5 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 7 May 2019 Belgian Biotech Raises €30M Series A to Unlock Undruggable Targets Confo Therapeutics has raised €30M in a Series A round that will take its unique technology to find drugs for historically undruggable targets to clinical trials. The fundraising was led by the VCs BioGeneration Ventures and Wellington Partners, and joined by several other private and public investors. With the money, Confo Therapeutics aims to […] May 7, 2019 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 1 May 2019 Next-Generation CAR-T Therapy Shows Promise in Child’s Neuroblastoma Cell Medica’s next-generation CAR-T cell therapy has resulted in ‘extensive tumor regression’ in a child with high-risk neuroblastoma, one of the deadliest types of childhood cancer. Only available to cancer patients for the last couple of years, CAR-T cell therapy has had impressive results in treating patients for whom other available options do […] May 1, 2019 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Interview 1 May 2019 What’s Driving the Boom in Early Stage Biotech Funding? The biotech industry is seeing a massive increase in the amount of funding available to early-stage research. At Bio Europe Spring, we spoke to Nerida Scott, VP of New Ventures and Transactions at Johnson & Johnson Innovation, to learn more about what’s behind it. In the last five years, the total invested in seed and […] May 1, 2019 - 4 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 30 Apr 2019 Cosmetics Giant Acquires German Biotech’s Spider Silk Cosmetics Arm The Swiss Givaudan, one of the largest cosmetics, flavors and fragrances companies in the world, has acquired the cosmetics business of AMSilk, a biotech company that uses genetic engineering to produce spider silk proteins in bacteria. Silk is a valuable material in the cosmetics industry, used to offer protection against pollution and keep cosmetic […] April 30, 2019 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 23 Apr 2019 Combining DNA and RNA Testing Could Improve Precision Medicine for Cancer An international clinical trial has shown that extending cancer testing beyond genetic mutations has potential to improve the personalized treatment of cancer. In recent years, the field of precision medicine has been rapidly growing and is bringing a lot of hope to both patients and physicians, especially in the diagnosis and treatment of […] April 23, 2019 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Interview 17 Apr 2019 What Does the Future Hold for European Biotech? Insights from Evotec’s CEO As the CEO of Evotec, one of Europe’s largest biotech companies, Werner Lanthaler is in a unique position to look into the future of the biotech industry. At Labiotech Refresh in Vienna, Lanthaler shared his views on where the industry is headed — and how to stay ahead of the game. The last decade has […] April 17, 2019 - 7 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Best in Biotech 15 Apr 2019 The Best Universities to Study Biotechnology in Europe Choosing the right university and program to study biotechnology can seem an insurmountable task, especially given the growing number of universities that offer courses in this booming field of study. We did some digging around to find a range of biotechnology programs with different specializations in some of the best universities in Europe. Each country […] April 15, 2019 - 14 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email